Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

1WD8

Calcium free form of human peptidylarginine deiminase type4 (PAD4)

1WD8 の概要
エントリーDOI10.2210/pdb1wd8/pdb
関連するPDBエントリー1WD9 1WDA
分子名称Protein-arginine deiminase type IV (1 entity in total)
機能のキーワードpost-translational enzyme, hydrolase
由来する生物種Homo sapiens (human)
細胞内の位置Cytoplasm: Q9UM07
タンパク質・核酸の鎖数1
化学式量合計74817.74
構造登録者
Arita, K.,Hashimoto, H.,Shimizu, T.,Nakashima, K.,Yamada, M.,Sato, M. (登録日: 2004-05-12, 公開日: 2004-07-13, 最終更新日: 2024-03-13)
主引用文献Arita, K.,Hashimoto, H.,Shimizu, T.,Nakashima, K.,Yamada, M.,Sato, M.
Structural basis for Ca(2+)-induced activation of human PAD4
Nat.Struct.Mol.Biol., 11:777-783, 2004
Cited by
PubMed Abstract: Peptidylarginine deiminase 4 (PAD4) is a Ca(2+)-dependent enzyme that catalyzes the conversion of protein arginine residues to citrulline. Its gene is a susceptibility locus for rheumatoid arthritis. Here we present the crystal structure of Ca(2+)-free wild-type PAD4, which shows that the polypeptide chain adopts an elongated fold in which the N-terminal domain forms two immunoglobulin-like subdomains, and the C-terminal domain forms an alpha/beta propeller structure. Five Ca(2+)-binding sites, none of which adopt an EF-hand motif, were identified in the structure of a Ca(2+)-bound inactive mutant with and without bound substrate. These structural data indicate that Ca(2+) binding induces conformational changes that generate the active site cleft. Our findings identify a novel mechanism for enzyme activation by Ca(2+) ions, and are important for understanding the mechanism of protein citrullination and for developing PAD-inhibiting drugs for the treatment of rheumatoid arthritis.
PubMed: 15247907
DOI: 10.1038/nsmb799
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.8 Å)
構造検証レポート
Validation report summary of 1wd8
検証レポート(詳細版)ダウンロードをダウンロード

229380

件を2024-12-25に公開中

PDB statisticsPDBj update infoContact PDBjnumon